Cervical cancer trials in Belgium
8 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleA Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)
- Where
- Charleroi, Edegem, Gent, Leuven, Liège, Sint-Lambrechts-Woluwe
- Age
- 18 years and over
- People
- 1,023 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT07216703 · EU 2025-521514-26-00 - Phase 2Taking peopleA Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
- Where
- Brussels, Edegem, Ghent, Jette, Leuven
- Age
- 18 years and over
- People
- 740 worldwide
- Run by
- Daiichi Sankyo
See details and how to joinNCT06172478 · EU 2023-507641-29-00 - Phase 1/2Taking peopleA Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
- Where
- Charleroi, Gent, Leuven, Liège, Sint-Lambrechts-Woluwe
- Age
- 18 years and over
- People
- 680 worldwide
- Run by
- Daiichi Sankyo
See details and how to joinNCT06330064 · EU 2023-509632-26-00 - Phase 1/2Taking peopleFirst-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
- Where
- Anderlecht, Leuven
- Age
- 18 years and over
- People
- 880 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT05768139 · EU 2023-504807-94-00 - Phase 2Taking peopleA basket study to investigate the efficacy and safety of SKB264 in combination with pembrolizumab in subjects with solid tumors
- Where
- Brasschaat, Charleroi, Sint-Lambrechts-Woluwe
- Age
- 18 years and over
- People
- 101 worldwide
- Run by
- Sichuan Kelun-Biotech Biopharmaceutical Co. Ltd.
See details and how to joinNCT05642780 · EU 2022-502654-14-00 - No phaseNot yet taking people in BelgiumHospital-based Validation of the New ELEVATE Screening Tool
- Where
- Ghent
- Age
- 30 years to 65 years
- People
- 200 worldwide
- Run by
- University Hospital, Ghent
See details and how to joinNCT06304610 - No phaseTaking peopleDeveloping a Combined Molecular Screening and Triage Test for Cervical Cancer in Self-samples
- Where
- Edegem
- Age
- 25 years to 64 years
- People
- 100
- Run by
- Universiteit Antwerpen
See details and how to joinNCT06598176 - Phase 3Taking peopleIntermediate Risk Cervical Cancer: Radical Surgery +/- Adjuvant Radiotherapy
- Where
- Gent, Leuven, Liège, Namur, Sint-Lambrechts-Woluwe
- Age
- 18 years to 85 years
- People
- 514 worldwide
- Run by
- The Central and Eastern European Gynecologic Oncology Group
See details and how to joinNCT04989647 · EU 2023-504973-19-01